Confúcio Moura

Confúcio Aires Moura, born in Dianópolis/TO, is a Brazilian physician and politician who served two terms as governor. Currently, he is serving his first term as a senator for Rondônia and is affiliated with the Brazilian Democratic Movement (MDB) . He graduated in medicine from the Federal University of Goiás (UFG) in 1975 and, before entering public life, was a sergeant in the Goiás military police.

Political Career

He began his political career when he was elected federal deputy for Rondônia three times consecutively, in 1994, 1998, and 2002. In 2004, he was elected mayor of Ariquemes, resigning his deputy mandate, and was re-elected mayor in 2008. In the 2010 Rondônia state elections, he was elected governor of the state in the second round, with 422,707 votes, or the equivalent of 58.68% of the valid votes.

In the 2014 election, he was re-elected for a second term as governor, where he remained until April 5, 2018, when he resigned to run for the Senate. In the 2018 state election, he was elected senator with 230,361 votes, equivalent to 17.06% of the valid votes.

Performance in the National Congress

The senator stands out for his advocacy of effective measures to curb illegal deforestation and promote forest regeneration, in order to mitigate the impacts of climate change. Furthermore, he argues that education is the key to the country's development.

Among his main achievements, the following stand out:

• He is the author of Bill 1942/2023 , which establishes a financial incentive called Bolsa Futuro, intended for low-income students completing basic education.

• He is the author of Bill 1709/2024 , which amends Law No. 9,394, of December 20, 1996, which "establishes the guidelines and bases of national education," to provide for the acceleration of studies for students with high abilities or giftedness.

• He was the rapporteur for Bill 6172/2023 , which amends Law No. 8,080, of September 19, 1990 (Organic Health Law), to establish a maximum period of one hundred and eighty days for the SUS (Brazilian Public Health System) to offer new medicines, products and procedures, or clinical protocols and therapeutic guidelines, counted from the date of publication of the incorporation decision.